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Abstract. [Purpose] The purpose of this study was to propose potential preventive measures against future mo-
bility impairments and muscle loss in healthy young adults by comprehensively evaluating their status of frailty, lo-
comotive syndrome, and sarcopenia. [Participants and Methods] A total of 83 Japanese young adults were enrolled 
in this study and evaluated using the diagnostic criteria for frailty (Japanese version of the Cardiovascular Health 
Study), locomotive syndrome (calculated as scores of the LOCOMO-25, the stand-up test, and two-step test), and 
sarcopenia (handgrip strength, usual gait test, skeletal muscle index). [Results] The prevalence of frailty-prefrailty 
(45.9%) was higher than that of presarcopenia (22.3%) and locomotive syndrome (14.1%). The prevalence of com-
binations of frailty-prefrailty and presarcopenia; frailty-prefrailty and locomotive syndrome; and frailty-prefrailty, 
locomotive syndrome, and pre-sarcopenia was 9.4%, 4.7%, and 3.5%, respectively. [Conclusion] Only 40% of the 
participants did not meet the three diagnostic criteria. On the other hand, there were not many participants with 
sarcopenia and/or locomotive syndrome diagnoses, suggesting that the improvement in intrinsic skeletal muscle 
mass rather than physical function is important for healthy Japanese young adults and could possibly be protective 
against future mobility or muscle-loss disorders.
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INTRODUCTION
Loss of skeletal muscle mass and sarcopenia are related to adverse health effects including falls, fractures, disability, 
and heart disease1–3), as well as increased healthcare costs and decreased healthy life expectancy4). Therefore, determining 
preventive measures against sarcopenia is particularly important in avoiding future mobility and frailty problems in currently 
healthy young adults. Thus, the European Working Group on Sarcopenia in Older People (EWGSOP) and the Asian Working 
Group for Sarcopenia (AWGS) introduced recommendations for evaluating skeletal muscle index (SMI, defined by appen-
dicular skeletal muscle mass/height2)), muscle strength (handgrip), and physical capability (gait speed) for diagnosing and 
assessing sarcopenia5, 6). Recent studies revealed that the ratio of presarcopenia (low SMI without impact on muscle strength 
or physical capability) was found in approximately one to two-thirds of healthy young females in Japan7, 8).
Frailty is known to be highly prevalent in older adults and is a risk factor adverse health outcomes, including falls, hospi-
talization, and mortality9). Therefore, frailty should be identified as early as possible, and preventive measures using effective 
criteria are needed to support healthcare in aging populations10, 11). The Japanese Orthopedic Association (JOA) proposed the 
concept of locomotive syndrome (LS) in 200712), defined as reduced mobility due to impaired locomotor organs. Preventive 
measures against LS should become a meaningful precedent not only for Japan, but also for other countries with rapidly 
aging societies. Therefore, preventive actions against frailty and LS should be taken from a young age, in order to avoid 
future mobility issues or diagnoses like sarcopenia.
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Since frailty, LS, and sarcopenia do not exist independently of each other, preventative measures should protect against 
all three dysfunctions, despite the fact that their exact relationships to each other are unclear. Thus, the purpose of this study 
was to propose potential preventive measures against future mobility impairments and muscle loss in healthy young adults 
by comprehensively evaluating their status of frailty, locomotive syndrome, and sarcopenia. In this study, we decided that the 
three diagnostic criteria mainly used in older adults are also applied to young adults, because it has been reported that there 
are a certain proportion of even young adults who have presarcopenia7, 8) or locomotive syndrome13). This suggests that it is 
important to examine the values of the three diagnostic criteria regardless of age. The originality and novelty of this study 
is that 1) it was targeted at young adults and 2) it comprehensively utilized of the three diagnostic criteria to understand the 
current state of bedridden prevention from an early stage of lifestyle.
PARTICIPANTS AND METHODS
A total of 83 Japanese male and female university students aged 18–20 years were recruited through oral communications 
in a “sports practice” course at our university. There were no participants with musculoskeletal disease and a history of 
knee joint surgery, all participants took “sports practice” without any problems. Before informed consent was obtained, a 
written description of the purpose of the study and its safety was distributed to potential participants, along with a lifestyle 
questionnaire. The participants in this study were classified as “recreationally active”; 46 (12 for male and 34 for female) 
of 83 participated in regular aerobic-type exercise (walking, jogging, or cycling; 2–3 times per week for approximately 30 
minutes). None of the participants had participated in strength/resistance-type training for 6 months before the start of the 
study. All participants were free of overt chronic disease (e.g., diabetes, angina, myocardial infarction, cancer, and stroke) 
as assessed by their annual medical examination. All 83 young adults included who met the criteria were included in the 
data analyses. The principles of the World Medical Association Declaration of Helsinki and the American College of Sports 
Medicine Guidelines for the Use of Human Participants were adopted in this study. The study was approved by the ethics 
committee of the Seirei Christopher University (approval number: 19087).
The Japanese version of the Cardiovascular Health Study (J-CHS) criteria questionnaire were as follows, with the respec-
tive answers that indicated potential frailty: (1) Have you lost 2 kg or more in the past 6 months? “Yes”, (2) Do you engage 
in moderate levels of physical exercise or sports aimed at health? Do you engage in low levels of physical exercise aimed at 
health? “No” to both questions, (3) In the past 2 weeks, have you felt tired without a reason? “Yes”, (4) grip strength <26 kg 
in men or 18 kg in women, and (5) gait speed <1.0 m/s. Frailty, prefrailty, and robustness were defined by having three to 
five, one to two, and zero items, respectively11).
The diagnostic criteria for LS were as follows: (1) self-rated locomotive function, (2) stand-up ability (knee extension 
torque), and (3) walking ability. These outcomes were calculated as scores of the LOCOMO-25, stand-up test, and two-step 
test, respectively. The scoring criteria of LOCOMO-25 followed the 25-question geriatric locomotive function scale14). The 
scoring criteria of the stand-up test and two-step test followed the scoring system of each test15). Based on the scores of three 
tests as a guide to assessing the risk of locomotive syndrome, the scores was classified into three stages as follows. Stage 1, if 
any of the three conditions (a-c) were met: (a) stand-up test, difficulty in standing from a 40-cm high seat using one-leg (either 
leg); (b) two-step test, <1.3; (c) 25-question score, ≥7). Stage 2, if any of the three conditions (a–c) were met: (a) stand-up 
test, difficulty in standing from a 20-cm high seat using both legs (either leg); (b) two-step test, <1.1; (c) 25-question score, 
≥16). Robust: did not meet criteria for stages 1 or 2. The diagnostic criteria were reported previously16).
Body mass and standing height were measured to the nearest 0.1 kg and 0.1 cm, respectively, by using a standing height 
scale and an electronic weight scale. Body mass index (BMI) was defined as body mass/height2 (kg/m2). A multi-frequency 
bioelectrical impedance analyzer (BIA), InBody 430 analyzer (Biospace Co., Ltd., Seoul, Korea) was used according to 
the manufacturer’s guidelines. BIA is used to estimate body composition according to the difference in conductivity of the 
various tissues based on the differences in their biological characteristics. This body composition analyzer adopts a tetrapolar, 
eight-point tactile electrode system that separately measures impedance of the arms, trunk, and legs at three different frequen-
cies (5, 50, and 250 kHz) for each segment. The measurements were carried out while the participants rested quietly in the 
supine position, with their elbows extended and relaxed along their trunk. The InBody automatically estimates body weight, 
BMI, percent body fat, and lean soft tissue of the two upper limbs and two lower limbs. The skeletal muscle index (SMI; 
AMM/height2, kg/m2) was calculated as the sum of the two upper limbs and two lower limbs (AMM)5–7). The usual gait test 
was measured over a 6-m course5, 6).
Handgrip strength was measured using a factory-calibrated hand dynamometer (TKK 5401; Takei, Tokyo, Japan). All 
participants were instructed to maintain an upright standing position, arms at their sides, holding the dynamometer in the 
right hand with the elbow extended at 180° without squeezing their arm against their body. The size of the dynamometer’s 
handle was set to feel comfortable for the participant while squeezing the grip. Each participant underwent two trials, and the 
best value of each trial was used for analysis7).
Results are expressed as mean ± standard deviation for all variables. All data were analyzed using JMP software (version 
12.0 SAS Institute Inc., Tokyo, Japan). When the data were not normally distributed, non-parametric statistical analysis 
(Wilcoxon signed rank test) was used to identify differences between male and female groups. Statistical significance was set 
at p<0.05. Differences in each diagnostic criterion between males and females were examined using the χ2 test.
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RESULTS
Physical characteristics and clinical data are presented in Table 1. Anthropometry and morphological assessments were 
significantly higher in men than in women, except for BMI, thigh girth, and anterior thigh MTH (Table 1). There were no 
differences in functional assessments between males and females, except for handgrip and two-step test scores (Table 1). 
In J-CHS criteria questionnaire, there were no participants applying to “(5) gait speed<1.0 m/s”. In locomotive syndrome 
criteria, there were no participants applying to “(a) stand-up test, difficulty in standing from a 40-cm high seat using one-leg 
(either leg)” and “(b) two-step test, <1.3”. There were no significant differences in the ratios of frailty (p=0.076), locomo-
tive syndrome (p=0.274), and sarcopenia (p=0.478) between the male and female groups (Tables 2–4). The prevalence of 
frailty-prefrailty (45.9%) was higher than that of presarcopenia (22.3%) and locomotive syndrome (14.1%). The prevalence 
of combining frailty-prefrailty and pre-sarcopenia, combining frailty-prefrailty and locomotive syndrome, or combining 
frailty-prefrailty, locomotive syndrome, and presarcopenia was 9.4%, 4.7%, and 3.5%, respectively (Fig. 1).
DISCUSSION
The main findings of this study are as follows: First, approximately 60% of healthy Japanese young adults were identi-
fied as having any or all three diagnostic criteria. Second, there were not many participants with stage 2 sarcopenia and/or 
locomotive syndrome, unlike prefrailty and presarcopenia.
Table 1. The physical characteristics and clinical data in Japanese university male and female
Variable Male Female p-value
N 18 65 -
Age, years 18.7 (1.2) 18.4 (0.6) 0.526
Standing height, cm 168.9 (6.7)** 156.9 (5.0) 0.001
Body weight, kg 58.9 (6.3)** 51.5 (7.8) 0.001
BMI, kg/m2 20.4 (2.2) 20.9 (2.8) 0.561
% body fat 13.2 (4.5)** 26.3 (6.0) 0.001
Fat mass, kg 7.8 (3.3)** 13.9 (5.3) 0.001
Morphological assessment
Fat-free mass, kg 28.1 (3.1)** 20.3 (2.2) 0.001
SMI, kg/m2 7.47 (0.57)** 6.07 (0.54) 0.001
Thigh girth, cm 48.7 (4.1) 48.5 (4.5) 0.468
Calf girth, cm 35.4 (2.0)* 34.2 (2.9) 0.043
Anterior thigh MTH, cm 4.80 (0.65) 4.50 (0.64) 0.099
Posterior thigh MTH, cm 6.08 (0.50)** 5.54 (0.62) 0.001
Posterior calf MTH, cm 6.58 (0.45)** 5.98 (0.67) 0.001
Functional assessment
J-CHS, unit/5-question 0.7 (0.8) 0.7 (0.8) 0.613
Handgrip, kg 42.1 (6.5)** 27.0 (5.9) 0.001
Gait speed, sec/5 m 3.70 (0.55) 3.60 (0.56) 0.711
Two-Step test, m/m 1.71 (0.14)* 1.64 (0.10) 0.014
Stand-Up test, cm 12.9 (7.7) 17.6 (11.9) 0.190
25-Question GLFS, unit 2.7 (2.4) 3.6 (3.7) 0.456
Data are given as mean (standard deviation). BMI: Body mass index; J-CHS: Japanese ver-
sion of the Cardiovascular Health Study; MTH: muscle thickness; SMI: skeletal muscle mass 
index. **p<0.01, *p<0.05, male vs. female.
Table 2.  Comparison based on diagnostic criteria and their proportions of frailty (J-CHS) in Japanese university male and female
Categories Robust Prefrailty Frailty
Number of items None 1 2 3 4 5
Male (n=18) 11 (61.1%) 4 (22.2%) 1 (5.6%) 2 (11.1%) 0 (0.0%) 0 (0.0%)
Female (n=65) 33 (50.8%) 21 (32.3%) 10 (15.4%) 1 (1.5%) 0 (0.0%) 0 (0.0%)
J-CHS: Japanese version of the Cardiovascular Health Study.
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Standing height, body weight, and handgrip strength in the present study (Male: 168.9 cm, 58.9 kg, 20.4 kg/m2, 42.1 kg; 
Female: 156.9 cm, 51.5 kg, 20.4 kg/m2, 27.0 kg) were similar to the standard values for Japanese physical fitness (Male: 
171.1 cm, 63.0 kg, 21.4 kg/m2, 45.8 kg [19 years]; Female: 158.7 cm, 52.2 kg, 20.7 kg/m2, 28.4 kg [19 years])17). Thus, it 
appears that the physical characteristics and muscle strength observed in this study represent the current general population 
of healthy Japanese young adults.
Interestingly, the prevalence of frailty and prefrailty was 46% in the young adults in this study. The concept of frailty 
includes “weight loss”, “low levels of physical exercise” and “feeling tired”, so there is a high possibility that even healthy 
young adults with no pre-disease states are vulnerable to these situations. J-CHS is one of the gold standards in Japan11), but 
it is necessary to note that J-CHS contains multiple indices that could be applicable to young adults with no dysfunction.
As in previous studies7, 8), young adults were vulnerable to pre-sarcopenia but not to sarcopenia. In addition, there were few 
young adults who appeared to demonstrate stage 2 locomotive syndrome. In Japan, previous studies demonstrated a decrease 
in physical strength from a young age compared to over 30 years ago18), but our results revealed that the effect of morphology 
(skeletal muscle mass) is greater than that of functional (muscle strength, activities of daily living, etc.). In general, regular 
medical examinations and physical fitness tests are thought to be one of the most important health markers regardless of 
age and gender, and they are widely performed using anthropometric measurements and field-based simplified methods at 
the national level in Japan19). However, only body weight measurement, not body fat percentage or skeletal muscle mass, is 
generally used in regular medical examinations in Japan20). Evaluations using body fat percentage and skeletal muscle mass 
rather than body weight should be adopted for assessing health from a young age, as differentiating between a patient’s lean 
muscle relative to fatty tissue could be a way to preventatively measures presarcopenia situations. For healthy young women, 
calf girth measurement is simplified morphological methods, but which could be an effective method to evaluate skeletal 
muscle mass even if the body fat percentage cannot be measured without a body composition analyzer21). Taken together, 
these results suggest that the improvement of intrinsic skeletal muscle mass (resistance training, etc.) rather than physical 
function is important for healthy Japanese young adults to extend healthy life expectancy in the future.
The present study has some limitations. First, as the participants were young Japanese adults, the age distribution and 
Fig. 1. The number of frailty-prefrailty, locomotive syndrome stage 1 & 2, 
and presarcopenia in healthy Japanese young adults (n=85).
Table 4. Comparison based on diagnostic criteria and their proportions of  
sarcopenia in Japanese university male and female
Category Robust Presarcopenia Sarcopenia
Male (n=18) 15 (83.3%) 3 (16.7%) 0 (0.0%)
Female (n=65) 49 (75.4%) 16 (24.6%) 0 (0.0%)
Table 3. Comparison based on diagnostic criteria and their proportions of  
locomotive syndrome in Japanese university male and female
Category Robust Stage 1 Stage 2
Male (n=18) 18 (100%) 0 (0.0%) 0 (0.0%)
Female (n=65) 53 (81.5%) 11 (16.9%) 1 (1.5%)
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physical characteristics were very limited. Second, the sample size was small. Future studies using a robust experimental 
design with a large sample size should be conducted to verify the findings of this study. In particular, the sample size of male 
participants was small, so it was difficult to discuss gender differences in this study. Therefore, additional research on these 
issues is required.
In conclusion, only approximately 40% of healthy Japanese young adults did not meet diagnostic criteria for frailty, 
sarcopenia, or LS. On the other hand, there were not many participants with existing sarcopenia and/or locomotive syndrome, 
suggesting that the improvement of intrinsic skeletal muscle mass rather than physical function is important for healthy 
Japanese young adults.
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